OA05.04 Sacituzumab Govitecan + Pembrolizumab in 1L Metastatic Non-Small Cell Lung Cancer: Preliminary Results of the EVOKE-02 Study
Year: 2023
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: B.C. Cho, M.C. Dols, R. Reyes Cabanillas, D. Vicente Baz, J. Fuentes Pradera, S. Grisanti, A.E. Gabayan, K.H. Lee, E.K. Cho, S. Mekan, F. Safavi, N. Fernando, M.J. Chisamore, M. Reck
Institutions: Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Hospital Clínic de Barcelona, Hospital Universitario Virgen Macarena, Hospital Universitario de Valme, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Beverly Hills Cancer Center, Chungbuk National University Hospital, Gachon University Gil Medical Center, Gilead Sciences (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), German Center for Lung Research, LungenClinic Grosshansdorf
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4388089510